CÇCan Çokçalışkan

Can Çokçalışkan

*This is an algorithmically generated author record based on publicly available information.

Can Çokçalışkan has a total of 94 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Buffaloed in Brandenburg: Germany’s first brush with foot-and-mouth disease after four decades of freedom

    by Michael Eschbaumer, Christoph Staubach, Florian Pfaff, Jörn Gethmann, Katja Schulz, Lisa Rogoll, Sabine Bock, Wulf-Iwo Bock, Christoph Schulze, Ronny Marquart, et al.

    Foot-and-mouth disease (FMD) virus is one of the most feared and most consequential pathogens of livestock worldwide. It can be spread rapidly by the transboundary movement of animals, animal products, and by-products. In January 2025, Germany detected its first FMD outbreak since 1988 in extensively reared water buffalo on a small farm in the state of Brandenburg, directly outside Berlin, the federal capital. Immediate control measures including a standstill for movements of susceptible animals and pre-emptive culling were implemented by the veterinary authorities. Whole-genome sequencing identified the virus as serotype O, topotype ME-SA, lineage SA-2018 and revealed extensive recombination, but cross-neutralization assays suggested good heterologous protection by an O/PanAsia-2 vaccine strain. Epidemiological back-calculation placed the time of virus introduction in late December 2024. Although the entry route remains unresolved, human-associated introduction is most likely. Network analysis revealed minimal farm connectivity, and simulations predicted low potential for onward transmission, which is consistent with the outbreak being ultimately restricted to a single herd. This event underscores the constant and unpredictable risk of introduction of the virus. Early detection through increased awareness and comprehensive differential diagnostics as well as the international collaboration of veterinary services, laboratories, and experts are essential in the face of the global presence of FMD.

  • Utilization of Chitosan as an Immune Response Enhancer in Non-Acidic Vaccine Formulations

    by Tuncer Turkoglu, Can Cokcaliskan, Erdogan Asar

    The unique properties of chitosan make it stand out as an ideal adjuvant candidate. However, the low solubility of chitosan in non-acidic aqueous media limits its use as an adjuvant. In this study, a method was offered to overcome this limitation, without any structural modifications of chitosan. The proposed method incorporated the preparation of Pickering emulsions via self-aggregation of the chitosan particles. As a model for this preparation, a w/o/w emulsion formulation of the foot-and-mouth disease (FMD) vaccine was utilized. Two vaccine formulations, with and without chitosan, were prepared and compared regarding their physicochemical properties. Laboratory animal (guinea pigs) trials were conducted to reveal the immune response in terms of neutralizing antibody levels. The sera were collected from two animal groups and tested for neutralizing antibody levels using a homologous virus neutralization test (VNT). Statistical analyses of the test results were performed at a 5% significance level using Quasi-Least Squares Regression (QLS). The incorporation of chitosan into the w/o/w vaccine formulation did not compromise the physicochemical properties of the emulsion. Statistical analysis reveals that the presence of chitosan enhances the antibody response. The effect of time and group on the neutralizing antibody titer levels (NATL) was found to be significant (p < 0.05). Our results suggest that the limitation of the use of chitosan as an adjuvant could be overcome by the Pickering emulsion preparation approach, without a need for further structural modifications. The presence of chitosan in such a vaccine formulation could enhance the immune response.

  • Duration of the antibody response following intradermal administration of a quarter-dose oil adjuvant foot-and-mouth disease vaccine in sheep

    by Tunçer Türkoğlu, Ünal Parlak, Pelin Tuncer-Göktuna, Eylem Aras-Uzun, Sena İnEl-Turgut, Erdoğan Asar, Ayça Kürkçü, Can Çokçalışkan

    Foot-and-mouth disease is a significant viral disease affecting cloven-hoofed domestic and wild animals. One of the most effective measures for combating this disease is vaccination. However, sheep are often excluded from vaccination campaigns because of vaccine shortages. Intradermal vaccination can significantly reduce the quantity of antigens and adjuvants required, thereby increasing vaccine availability. Although numerous experimental studies have been conducted on the intradermal administration of the FMD vaccine, no such studies have been conducted on sheep, and the duration of antibody response for this species remains unclear. Inactivated antigens for foot-and-mouth disease, including O/Panasia-II, A/IRN-05, A/ASIA/G-VII, and ASIA1/Sindh-08, were formulated using ictyolane 18 and ictyolane 30 adjuvants to prepare water-in-oil-in-water and microemulsions. Forty-five Merino sheep were randomly divided into four groups of 10 animals each, with one unvaccinated group containing five animals. One mL of vaccine (> 3PD50) was administered intramuscularly to the intramuscular groups (IM18 and IM30), whereas 1/4 mL was administered intradermally to intradermal groups (ID18 and ID30). A booster dose was administered to all groups on day 28. Blood samples were collected from the sheep at various intervals: days 0, 7, 14, 28, 58, 86, 118, 151, 179, 211, 241, 270, 302, 338, and 361. Serum antibody levels were determined using VNT and LPB-ELISA. No difference was observed between the reduced-dose intradermal and full-dose intramuscular administration of Ictyolane 18 (ICT18) vaccine formulation (p > 0.05) in terms of antibody level and duration in sheep. It has been observed that the Ictyolane 18 formulations generally stimulate a higher antibody response than the Ictyolane 30 formulations.

  • Open Access

    Şap Hastalığı Teşhisi için Enzim Immunotransfer Blot Testinin kantitatif bir yaklaşım ile iyileştirilmesi

    by Can Çokçalişkan, Ünal Parlak, Beyhan Sareyyüpoğlu, Abdülnaci Bulut, Ayca Babak, Fuat Özyörük

    Foot-and-mouth disease (FMD) is a highly contagious animal disease that causes devastating economic losses. The trade of live animals and derived products is only possible if the exporting country is free from disease, according to the World Organization for Animal Health (WOAH) code for FMD. One of the most important ways to prove disease-free is to measure the levels of non-structural protein antibodies (NPS) of FMD virus in the target population sampled. For detection of the disease status of a herd, mass screening and assays such as Enzyme-linked immunosorbent assay (ELISA) and Enzyme-linked immunoelectrotransfer blot assay (EITB) were developed and described in the WOAH diagnostic manual. In this study, recombinant FMDV NS proteins were produced and tested with sera panels collected from uninfected and naturally infected animals using a quantitative Western blot assay as an improved EITB, which enables numerical documentation and statistical analysis. NSP band intensities were used to determine the cut-off values, differentiating infected from non-infected animals and revealing variable sensitivity among the different NSPs. The quantitative EITB results also showed a correlation with the NSP-ELISA results.


  • Evaluation of Quil-A, E. coli DNA and Montanide™ ISA 206 adjuvant combination on the antibody response to foot-and-mouth disease vaccine in sheep

    by Can Çokçalişkan, Tunçer Türkoğlu, Beyhan Sareyyüpoğlu, Pelin Tuncer-Göktuna, Banu Bayri Özbilge, Ergün Uzunlu, Ayça Kürkçü, Eylem Aras Uzun, Veli Gülyaz

    Evaluation of Quil-A, E. coli DNA and Montanide™ ISA 206 adjuvant combination on the antibody response to foot-and-mouth disease vaccine in sheep


  • Booster administration can make a difference in the antibody response to intradermal foot-and-mouth disease vaccination in cattle

    by Can Çokçalışkan, Pelin Tuncer-Göktuna, Beyhan Sareyyüpoğlu, Tunçer Türkoğlu, Muhammet Yıldız, M. Nuri Fırat Deveci, Eylem Aras-Uzun, Abdullah Arslan, Ayça Kürkçü, Ergün Uzunlu, et al.

    Foot-and-mouth disease (FMD) is a highly contagious and economically important viral disease of cloven-hoofed animals. Routine vaccination is one of the preferred methods of protection against this disease in endemic countries. For protective immunity against FMD, repeated immunizations with frequent administration are required. Intradermal immunization has many advantages over intramuscular administration of vaccines. In this study, a commercial tetravalent FMD vaccine adjuvanted with Montanide ISA 206 was administered to cattle via the intramuscular (2 mL [n = 10] and 0.5 mL [n = 9]) and intradermal (0.5 mL [n = 11]) routes. Booster doses were administered 28 days later using the same vaccine and routes. Serum samples were collected on days 0, 7, 14, and 28 post-vaccination (pv) and at 30 and 60 days post-booster. Homologous and heterologous virus neutralization tests and liquid-phase blocking and isotype ELISAs were used to measure the antibody response. The results showed that intradermal administration of quarter doses of the vaccine provides an equal or better virus neutralization antibody response than intramuscular administration of the same dose of vaccine after booster administration in cattle. This means that four times more cattle can be immunized with the same amount of vaccine using the intradermal route without compromising immunity.


  • Monitoring the performance of foot‐and‐mouth disease vaccines prepared against local strains in the face of antigenic evolution in the field

    by Pelin Tuncer‐Göktuna, Can Çokçalışkan, Abdullah Arslan, Neslihan Taşçene, Eylem Aras Uzun, Ceylan Gündüzalp, Gül Nazik Balcı, Osman Kara, Veli Gülyaz

    The national program for foot‐and‐mouth disease (FMD) eradication includes the use of vaccination; Turkey is endemic to FMD virus (FMDV) (except for the Thrace region) and there is a risk of incursion of exotic strains from eastern borders. In 2015 a devastating outbreak was caused by the A/ASIA/G‐VII lineage, which led to the inclusion of a new vaccine strain derived from this lineage (A/TUR/15) in three months. Although most of the cattle population in Turkey was then immunized with A/TUR/15 (vaccine coverage: 92.8%), the G‐VII lineage continued to cause outbreaks in the field despite the evidence of protection observed with A/TUR/15 in in‐vivo and in‐vitro tests. When A/ASIA/G‐VII field strains were examined, changes in their genomes were detected. As the lineage appeared to be evolving, an unconventional vaccination strategy was adapted which changed the vaccine strain with new variants of A/ASIA/G‐VII according to antigenic evolution. To assess the suitability of candidate vaccine strains derived from the variants of the A/ASIA/G‐VII lineage, three viral candidates were assessed (A/TUR/15, A/TUR/16 and A/TUR/17) by in‐vitro virus neutralization tests for r1 vaccine matching and in‐vivo heterologous challenge tests. Although all three vaccine strains were antigenically well matched with each other and other G‐VII field viruses, due to continues outbreaks the vaccine strain was changed three times in 20 months from A/TUR/15 (Dec 2015) to A/TUR/16 (Dec 2016) and then to A/TUR/17 (Aug 2017). Serotype A has not been observed in the field since January 2018. This study highlights the importance of adapting the vaccine strains according to antigenic evolution as this could be a valuable combat strategy in endemic countries, rather than using well‐known vaccine strain and relying only on the relationship coefficient (r1) value.


  • Open Access

    Determination of non-structural protein level for Turkey foot-and-mouth disease vaccine antigens during in-process

    by Beyhan Sareyyüpoğlu, Can Çokçalışkan, Aydın Çoskuner, Veli Gülyaz

    Sareyyüpoğlu B, et al. Clin Exp Vaccine Res. 2020 Jul;9(2):97-101. https://doi.org/10.7774/cevr.2020.9.2.97


  • Open Access

    Effect of simultaneous administration of foot-and-mouth disease (FMD) and anthrax vaccines on antibody response to FMD in sheep

    by Can Çokçalışkan, Pelin Tuncer Göktuna, Tunçer Türkoğlu, Ergün Uzunlu, Ceylan Gündüzalp, Eylem Aras Uzun, Beyhan Sareyyüpoğlu, Ayça Kürkçü, Veli Gülyaz

    Purpose: Foot-and-mouth disease (FMD) and anthrax are important diseases in sheep. Vaccination is a favorable strategy against both infections. Simultaneous administration of vaccines does generally not impede the immune responses of each other, although there are some exceptions, and it may help reduce the labor and costs of vaccination as well as distress on animals. Although oil adjuvant FMD vaccine has been tried with live anthrax vaccine in cattle, there are no reports on the simultaneous use of both vaccines in sheep. Materials and Methods: In this study, FMD seronegative sheep were used to investigate the impact of the simultaneous vaccination of FMD and anthrax on FMD antibody titers of sheep. Virus neutralization test and liquid phase blocking enzyme-linked immunosorbent assay were used to determine the antibody response to the FMD vaccine. Results: The results demonstrated that both vaccines can be used simultaneously without any interference with the FMD response. Moreover, the simultaneous administration with anthrax vaccine had a stimulating effect on the early (day 7 post-vaccination) virus neutralization antibody response to the FMD vaccine. Conclusion: The simultaneous use of the FMD and anthrax vaccines did not hinder the response to the FMD vaccine in sheep.


  • Open Access

    Influence of vaccine potency and booster administration of foot-and-mouth disease vaccines on the antibody response in calves with maternal antibodies

    by Can Çokçalışkan, Tunçer Türkoğlu, Ergün Uzunlu, Beyhan Sareyyüpoğlu, İbrahim Hancı, Ahmet İpEk, Abdullah Arslan, Ayca Babak, Gülnur İlDeniz, Veli Gülyaz

    Çokçalışkan C, et al. J Vet Sci. 2017 Aug;18(S1):315-322. https://doi.org/10.4142/jvs.2017.18.S1.315